Amarin Corp (AMRN) Stock Price, Quote, News & History

Amarin Corp PLC (AMRN) Stock Price, Quote, News & History

AMRNNASDAQ

Trade with Public

$15.20

0.654.47%

At close: Apr 15, 5:00 PM EST

$14.33

-0.87-5.71%

After Hours: Apr 9, 5:19 PM EST

Earnings: Q1 2026 Earnings in 13 days from now on Wed Apr 29th, before the market open

Key Statistics

Open

$14.48

$15.20

Volume / Avg.

53.80K / 74.12K

Day Range

$14.40 - $15.20

52 Wk Range

8.32 - 20.90

Market Cap

$300.59M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.21%

Days to Cover

10.12

Recent Amarin Corporation PLC News

Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA

Amarin Corporation (NASDAQ: AMRN) shares are trading higher Tuesday after the company announced a long-term exclusive license and supply agreement with Recordati S.p.A. to commercialize its cardiovascular drug VAZKEPA (icosapent ethyl) across 59 countries in Europe.

Vaishali Prayag

Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges

Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to improve cash flow

Vandana Singh

Top 3 Health Care Stocks You'll Regret Missing In Q4

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.73M

Investing Cash Flow (TTM)

8.83M

Financing Cash Flow (TTM)

-2.03M

Free Cash Flow (TTM)

6.73M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

13.52M

Analyst Rating and Forecast

1.7

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.65M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

1.41

PB Ratio (TTM)

0.66

Earnings Yield % (TTM)

-12.37%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

44.87

Book Value / Share

$21.90

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$134.66M

Debt to Equity

0.01

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$14.48

$15.20

Volume / Avg.

53.80K / 74.12K

Day Range

$14.40 - $15.20

52 Wk Range

8.32 - 20.90

Market Cap

$300.59M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.21%

Days to Cover

10.12

About

Sector

Health Care

Industry

Biotechnology

Amarin Corp PLC is a pharmaceutical company. The company is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa. The company focuses...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Amarin Corp (AMRN) stock?

You can purchase shares of Amarin Corp (NASDAQ:AMRN) through any online brokerage.

View our list of the best stock brokerages

Who are Amarin Corp (AMRN) competitors?

Other companies in Amarin Corp’s space includes: Immuneering Corp (NASDAQ:IMRX), Palisade Bio Inc (NASDAQ:PALI), DiaMedica Therapeutics Inc (NASDAQ:DMAC), AC Immune SA (NASDAQ:ACIU) and Compugen Ltd (NASDAQ:CGEN).

What is the forecast, or price target, for Amarin Corp (AMRN) stock?

Amarin Corp has a consensus price target of $4.75.

What is the current price for Amarin Corp (AMRN)?

The stock price for Amarin Corp (NASDAQ: AMRN) is $14.3325 last updated April 9, 2026 at 5:19 PM EDT.

Does Amarin Corp (AMRN) pay a dividend?

There are no upcoming dividends for Amarin Corp.

When is Amarin Corp (NASDAQ:AMRN) reporting earnings?

Amarin Corp does not have any upcoming earnings scheduled.

Is Amarin Corp (AMRN) going to split?

There is no upcoming split for Amarin Corp.

What sector and industry does Amarin Corp (AMRN) operate in?

Amarin Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

DiaMedica Therapeutics Inc

Bicycle Therapeutics PLC

Silence Therapeutics PLC

NASDAQ:SLN

$7.15

-1.79%

Key Statistics

Open

$14.48

$15.20

Volume / Avg.

53.80K / 74.12K

Day Range

$14.40 - $15.20

52 Wk Range

8.32 - 20.90

Market Cap

$300.59M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.21%

Days to Cover

10.12

Recent Amarin Corporation PLC News

Amarin Shares Surge After $175M European Licensing Deal For Heart Drug VAZKEPA

Vaishali Prayag

Amarin Lands Massive European Commercialization Deal For Heart Drug Vazkepa, Stock Surges

Amarin signs $175 million Vazkepa deal with Recordati, plans global restructuring and targets $70 million in cost cuts to improve cash flow

Vandana Singh

Top 3 Health Care Stocks You'll Regret Missing In Q4

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

6.73M

Investing Cash Flow (TTM)

8.83M

Financing Cash Flow (TTM)

-2.03M

Free Cash Flow (TTM)

6.73M

Capital Expenditure (TTM)

Net Change in Cash (TTM)

13.52M

Analyst Rating and Forecast

1.7

Sell

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$8.65M

PE Ratio (TTM)

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

1.41

PB Ratio (TTM)

0.66

Earnings Yield % (TTM)

-12.37%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

Price / EBITDA (TTM)

Price / Free Cash Flow (TTM)

44.87

Book Value / Share

$21.90

Company Debt

Total Debt

LT Debt

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$134.66M

Debt to Equity

0.01

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$14.48

$15.20

Volume / Avg.

53.80K / 74.12K

Day Range

$14.40 - $15.20

52 Wk Range

8.32 - 20.90

Market Cap

$300.59M

P/E Ratio

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.21%

Days to Cover

10.12

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry